Propelled by strong shipping momentum, CVC Technologies (皇將) reported record-breaking figures for December, Q4, and the full year of 2025. Annual consolidated revenue reached NT$1.457 billion (+13.19% YoY).

Growth Drivers:

• Market Recovery: Demand for tablet counting and soft-gel encapsulation lines rebounded as global pharmaceutical packaging markets stabilized following clearer tariff policies.
• M&A Synergy: The 2023 acquisition of South Korean firm Changsung Softgel System is yielding cross-selling results in North America, India, and Europe, successfully penetrating several "Big Pharma" accounts.

2026 Strategic Roadmap:

1. Global Network: Strengthening hubs in Europe and Mexico while expanding in South America.
2. Product Innovation: Launching the U2 series and Intelligent Tumble Dryer (ITD) in Q1 2026, targeting the high-end "Smart Manufacturing" segment of the pharmaceutical industry.
3. Strategic Alliances: Seeking complementary technical partners to build long-term growth engines.

Resource: 皇將2025年營收創新高 製藥包裝需求回溫助攻全年年增逾13％